NCT04977180View on ClinicalTrials.gov

Cardioprotection in AML

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

March 31, 2028

Study Completion Date

September 30, 2028

Conditions
AMLAcute Myeloid Leukemia
Interventions
DRUG

Cardioprotection

Preventive beta blocker (metoprolol or carvedilol) and an ACE inhibitor (lisinopril)

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER